Skip to main content
. 2016 Jan 27;2016(1):CD009210. doi: 10.1002/14651858.CD009210.pub2

Fan 2016.

Methods Parallel randomized controlled trial
Participants Patients diagnosed with rheumatic valve diseases undergoing heart valve replacement operations
Interventions Telmisartan, captopril, and placebo
Outcomes Pulmonary vascular resistance, A‐aDO2, pulmonary neutrophil count, SOD malondialdehyde, NO, angiotensin II; Complications and hospital time.
Notes